StreetInsider.com News Articles

Form 8-K LifeMD, Inc. For: Mar 09

Mon, 09 Mar 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260309/26132809.html

Form 8-K LifeMD, Inc. For: Mar 09

Mon, 09 Mar 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260309/26132809.html

LifeMD, Inc. (LFMD) Tops Q4 EPS by 3c, provides guidance

Mon, 09 Mar 2026 16:09:44 -0400

LifeMD, Inc. (NASDAQ: LFMD) reported Q4 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $46.87 million versus the consensus estimate of $49.07 million.

GUIDANCE:

LifeMD, Inc. sees Q1 2026 revenue of $48-49 million, versus the consensus of $50.57 million.

LifeMD, Inc. sees FY2026 revenue of $220-230 million, versus the consensus of $222.6 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

LifeMD, Inc. (LFMD) Tops Q4 EPS by 3c, provides guidance

Mon, 09 Mar 2026 16:09:44 -0400

GUIDANCE:

LifeMD, Inc. sees Q1 2026 revenue of $48-49 million, versus the consensus of $50.57 million.

LifeMD, Inc. sees FY2026 revenue of $220-230 million, versus the consensus of $222.6 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

LifeMD Reports Fourth Quarter and Full Year 2025 Results

Mon, 09 Mar 2026 16:05:00 -0400

Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million.
Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.
Successfully launched oral Wegovy subsequent to year end, with over 80% of new weight management patients initiating branded therapy and Q1 sign-ups at record levels.
Exited 2025 with $36.8 million of cash and no debt, positioning LifeMD for accelerated investments in growth.
Benefits infrastructure on track to cover approximately 220 million Americans in second quarter; women’s health offering seeing strong early patient growth.

Conference call begins at 4:30 p.m. Eastern

LifeMD Reports Fourth Quarter and Full Year 2025 Results

Mon, 09 Mar 2026 16:05:00 -0400

Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million.
Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.
Successfully launched oral Wegovy subsequent to year end, with over 80% of new weight management patients initiating branded therapy and Q1 sign-ups at record levels.
Exited 2025 with $36.8 million of cash and no debt, positioning LifeMD for accelerated investments in growth.
Benefits infrastructure on track to cover approximately 220 million Americans in second quarter; women’s health offering seeing strong early patient growth.

Conference call begins at 4:30 p.m. Eastern

LifeMD Reports Fourth Quarter and Full Year 2025 Results

Mon, 09 Mar 2026 16:05:00 -0400

Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million.
Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.
Successfully launched oral Wegovy subsequent to year end, with over 80% of new weight management patients initiating branded therapy and Q1 sign-ups at record levels.
Exited 2025 with $36.8 million of cash and no debt, positioning LifeMD for accelerated investments in growth.
Benefits infrastructure on track to cover approximately 220 million Americans in second quarter; women’s health offering seeing strong early patient growth.

Conference call begins at 4:30 p.m. Eastern

LifeMD Reports Fourth Quarter and Full Year 2025 Results

Mon, 09 Mar 2026 16:05:00 -0400

Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million.
Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.
Successfully launched oral Wegovy subsequent to year end, with over 80% of new weight management patients initiating branded therapy and Q1 sign-ups at record levels.
Exited 2025 with $36.8 million of cash and no debt, positioning LifeMD for accelerated investments in growth.
Benefits infrastructure on track to cover approximately 220 million Americans in second quarter; women’s health offering seeing strong early patient growth.

Conference call begins at 4:30 p.m. Eastern

LifeMD Reports Fourth Quarter and Full Year 2025 Results

Mon, 09 Mar 2026 16:05:00 -0400

Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million.
Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.
Successfully launched oral Wegovy subsequent to year end, with over 80% of new weight management patients initiating branded therapy and Q1 sign-ups at record levels.
Exited 2025 with $36.8 million of cash and no debt, positioning LifeMD for accelerated investments in growth.
Benefits infrastructure on track to cover approximately 220 million Americans in second quarter; women’s health offering seeing strong early patient growth.

Conference call begins at 4:30 p.m. Eastern

LifeMD Reports Fourth Quarter and Full Year 2025 Results

Mon, 09 Mar 2026 16:05:00 -0400

Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million.
Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.
Successfully launched oral Wegovy subsequent to year end, with over 80% of new weight management patients initiating branded therapy and Q1 sign-ups at record levels.
Exited 2025 with $36.8 million of cash and no debt, positioning LifeMD for accelerated investments in growth.
Benefits infrastructure on track to cover approximately 220 million Americans in second quarter; women’s health offering seeing strong early patient growth.

Conference call begins at 4:30 p.m. Eastern

LifeMD to Participate in Two Investor Conferences During March

Tue, 03 Mar 2026 16:05:00 -0400

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of March:

Mizuho Securities Healthcare Technology Conference 2026, March 5. Management will hold virtual one-on-one meetings with investors throughout the day.
KeyBanc Capital Markets Healthcare Forum, March 17-18. Management will participate in a virtual fireside chat on Wednesday, March 18th at 9:00 a.m. Eastern time and a virtual panel titled “The Outlook for the GLP-1 Market:

LifeMD to Participate in Two Investor Conferences During March

Tue, 03 Mar 2026 16:05:00 -0400

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of March:

Mizuho Securities Healthcare Technology Conference 2026, March 5. Management will hold virtual one-on-one meetings with investors throughout the day.
KeyBanc Capital Markets Healthcare Forum, March 17-18. Management will participate in a virtual fireside chat on Wednesday, March 18th at 9:00 a.m. Eastern time and a virtual panel titled “The Outlook for the GLP-1 Market:

LifeMD to Participate in Two Investor Conferences During March

Tue, 03 Mar 2026 16:05:00 -0400

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of March:

Mizuho Securities Healthcare Technology Conference 2026, March 5. Management will hold virtual one-on-one meetings with investors throughout the day.
KeyBanc Capital Markets Healthcare Forum, March 17-18. Management will participate in a virtual fireside chat on Wednesday, March 18th at 9:00 a.m. Eastern time and a virtual panel titled “The Outlook for the GLP-1 Market:

LifeMD to Participate in Two Investor Conferences During March

Tue, 03 Mar 2026 16:05:00 -0400

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of March:

Mizuho Securities Healthcare Technology Conference 2026, March 5. Management will hold virtual one-on-one meetings with investors throughout the day.
KeyBanc Capital Markets Healthcare Forum, March 17-18. Management will participate in a virtual fireside chat on Wednesday, March 18th at 9:00 a.m. Eastern time and a virtual panel titled “The Outlook for the GLP-1 Market:

LifeMD to Participate in Two Investor Conferences During March

Tue, 03 Mar 2026 16:05:00 -0400

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of March:

Mizuho Securities Healthcare Technology Conference 2026, March 5. Management will hold virtual one-on-one meetings with investors throughout the day.
KeyBanc Capital Markets Healthcare Forum, March 17-18. Management will participate in a virtual fireside chat on Wednesday, March 18th at 9:00 a.m. Eastern time and a virtual panel titled “The Outlook for the GLP-1 Market:

LifeMD to Participate in Two Investor Conferences During March

Tue, 03 Mar 2026 16:05:00 -0400

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of March:

Mizuho Securities Healthcare Technology Conference 2026, March 5. Management will hold virtual one-on-one meetings with investors throughout the day.
KeyBanc Capital Markets Healthcare Forum, March 17-18. Management will participate in a virtual fireside chat on Wednesday, March 18th at 9:00 a.m. Eastern time and a virtual panel titled “The Outlook for the GLP-1 Market:

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

Mon, 23 Feb 2026 08:00:00 -0400

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.

Conference Call & Webcast Details

Date: NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.

Conference Call & Webcast Details

Date: NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.

Conference Call & Webcast Details

Date: NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.

Conference Call & Webcast Details

Date: NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.

Conference Call & Webcast Details

Date: NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.

Conference Call & Webcast Details

Date: